Morgan Lewis

Related Publications

09/18/14 SEC Targets Corporate Insiders for Failing to Promptly Disclose Stock Transactions
The Commission has announced an unprecedented enforcement initiative against officers, directors, and major stockholders for violating beneficial ownership reporting requirements and against public companies for their roles in contributing to or failing to disclose such violations.
05/16/14 Updated: No Stay of SEC’s Conflict Minerals Rules
Court denies emergency motion for a stay.
01/16/14 NASDAQ Amends Compensation Committee Independence Rules
Amendment eliminates prohibition on the receipt of compensatory fees and aligns NASDAQ listing rules with NYSE standards.  
View all publications

Related News

10/13/14 SEC’s Broken Windows Sweep a ‘Game-Changer’ for Directors, Agenda
Business and Finance of counsel Albert Lung is quoted.
08/19/10 Morgan Lewis Advises Phoenix Technologies on Acquisition by Marlin Equity Partners
On Tuesday, Phoenix Technologies Ltd. entered into a definitive merger agreement with Marlin Equity Partners, where Marlin will acquire all outstanding shares of Phoenix stock for $3.85 per share, or approximately $139 million.
View all news
Photo of  Albert Lung

bar admissions

  • California
  • New York
print profile

Albert Lung
Of Counsel


Email: alung@morganlewis.com
Silicon Valley
2 Palo Alto Square
3000 El Camino Real, Suite 700
Palo Alto, CA 94306-2121 USA
Phone: +1.650.843.7263
Fax: +1.650.843.4001
San Francisco
One Market, Spear Street Tower
San Francisco, CA 94105-1596
United States
Phone: +1.415.442.1366
Fax: +1.415.442.1001

Albert Lung is of counsel in Morgan Lewis's Business and Finance Practice. Mr. Lung's practice concentrates on capital market transactions, corporate governance, and securities laws. His practice focuses on representing companies, investment banks, and major stakeholders in a variety of corporate finance transactions, including IPOs, follow-on and secondary offerings, PIPEs, Rule 144A offerings, and convertible debt financing. Mr. Lung also counsels publicly listed companies, including technology, biotech, software, and life science companies on corporate governance, SEC regulations, legal compliance, NYSE and NASDAQ listing requirements, investors communications, and general corporate matters. His practice also includes advising companies located in the Asia-Pacific region in cross-border financing transactions and compliance with U.S. securities laws and disclosure requirements. Mr. Lung has represented clients in venture financing transactions, mergers and acquisitions, and other commercial transactions for companies in a variety of industries, with a focus on representing emerging technology and life science companies in the Silicon Valley. 

Prior to joining Morgan Lewis, Mr. Lung was an associate at a leading business and finance law firm in New York, where his practice included capital market transactions, secured financing, and advising private equity funds on matters relating to securities and corporate law.

Mr. Lung earned his J.D., magna cum laude, from Yeshiva University, Benjamin N. Cardozo School of Law in 2001, where he was the managing editor for the Cardozo Law Review and authored an article titled "Must-Carry Rules in the Transition to Digital Television: A Delicate Constitutional Balance." He earned his B.A., summa cum laude, in political science from New York University in 1998.

Mr. Lung is admitted to practice in California and New York.

education

  • Yeshiva University, Benjamin N. Cardozo School of Law, 2001, J.D., Magna Cum Laude
  • New York University, 1998, B.A., Summa Cum Laude